Business · 26/02/2019
FDA Publishes Revised Draft Guidance on Bioavailability Studies for New Drug Applications
The FDA has released a revised draft guidance for industry on bioavailability studies required for new drug applications and investigational new drug applications, updating recommendations from 2014.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →